We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+0.1%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$4.97B
AUM Growth
-$227M
Cap. Flow
-$120M
Cap. Flow %
-2.42%
Top 10 Hldgs %
24.91%
Holding
802
New
109
Increased
252
Reduced
267
Closed
54

Top Buys

Rank Stock Value
1
VTR icon
Ventas
VTR
+$29.1M
2
BMY icon
Bristol-Myers Squibb
BMY
+$28.3M
3
ECL icon
Ecolab
ECL
+$25.4M
4
MRK icon
Merck
MRK
+$24.7M
5
EW icon
Edwards Lifesciences
EW
+$20.9M

Sector Composition

Rank Sector Weight
1 Healthcare 18.75%
2 Consumer Discretionary 15.42%
3 Technology 15.27%
4 Financials 12.99%
5 Industrials 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNCN
601
DELISTED
BNC Bancorp
BNCN
-8,300
Closed -$211K
SWC
602
DELISTED
Stillwater Mining Co
SWC
-39,105
Closed -$335K
PCL
603
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
-5,806
Closed -$277K
PCP
604
DELISTED
PRECISION CASTPARTS CORP
PCP
-10,749
Closed -$2.49M
TW
605
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
-8,228
Closed -$1.06M
AMZG
606
DELISTED
AMERICAN EAGLE ENERGY CORP NEW COM STK (NV)
AMZG
$0 ﹤0.01%
16,592
QBC
607
DELISTED
CUBIC ENERGY INC
QBC
$0 ﹤0.01%
23,252
FUQI
608
DELISTED
FUQI INTERNATIONAL INC COM
FUQI
$0 ﹤0.01%
10,000
HWFG
609
DELISTED
HARRINGTON WEST FINL GROUP INC
HWFG
$0 ﹤0.01%
48,554
ABPI
610
DELISTED
Accentia Biopharmaceuticals
ABPI
$0 ﹤0.01%
10,925
TMA
611
DELISTED
THORNBURG MTG INC COM NEW (MD)
TMA
-66,000
Closed
LNKD
612
DELISTED
LinkedIn Corporation
LNKD
-82,131
Closed -$18.5M
MDVN
613
DELISTED
MEDIVATION, INC.
MDVN
-4,185
Closed -$202K
BQI
614
DELISTED
OILSANDS QUEST INC COM STK
BQI
$0 ﹤0.01%
+10,000
New

Similar funds

Geneva Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, Geneva Advisors held 802 positions worth $4.97B, down 4.4% from $5.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Geneva Advisors's Q1 2016 filing shows 109 new, 252 increased, 267 reduced and 54 closed positions. Its largest new stake was Ventas: 517,036 shares worth $32.6M. The largest sale was ServiceNow, an estimated $44M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Geneva Advisors's largest Q1 2016 buy was Ventas: 517,036 shares worth $32.6M.
  • Geneva Advisors added most to Bristol-Myers Squibb in Q1 2016, an estimated $28.3M increase.
  • Geneva Advisors's biggest Q1 2016 reduction was SBA Communications, cutting an estimated $43.3M.
  • Geneva Advisors fully exited ServiceNow in Q1 2016, selling an estimated $44M.
  • Geneva Advisors's ten largest holdings make up 25% of its $4.97B portfolio in Q1 2016.
  • Geneva Advisors opened 109 new positions and closed 54 in Q1 2016.
  • Geneva Advisors's portfolio value fell 4.4% quarter-over-quarter to $4.97B.

Based on Geneva Advisors's 13F filing for Q1 2016, filed 3 May 2016.